UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis

Annals of internal medicine, 2001-08, Vol.135 (4), p.248

2001

Volltextzugriff (PDF)

Clinical presentation and monitoring of lupus nephritis

Lupus, 2005-01, Vol.14 (1), p.25-30

Balow, J E

2005

Volltextzugriff (PDF)

Nephrotic syndrome: an under‐recognised immune‐mediated complication of non‐myeloablative allogeneic haematopoietic cell transplantation

British journal of haematology, 2005-10, Vol.131 (1), p.74-79

2005

Volltextzugriff (PDF)

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

The Lancet (British edition), 1992-09, Vol.340 (8822), p.741-745

1992

Volltextzugriff (PDF)

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial

Annals of internal medicine, 1996-10, Vol.125 (7), p.549

1996

Volltextzugriff (PDF)

Mapping of a Gene Causing Familial Mediterranean Fever to the Short Arm of Chromosome 16

The New England journal of medicine, 1992-06, Vol.326 (23), p.1509-1513

1992

Volltextzugriff (PDF)

Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates

Annals of internal medicine, 1993-12, Vol.119 (12), p.1198

1993

Volltextzugriff (PDF)

Treatment of Type B Insulin Resistance: A Novel Approach to Reduce Insulin Receptor Autoantibodies

The journal of clinical endocrinology and metabolism, 2010-08, Vol.95 (8), p.3641-3647

2010

Volltextzugriff (PDF)

Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis

Rheumatology (Oxford, England), 2007-06, Vol.46 (6), p.952-956

2007

Volltextzugriff (PDF)

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

JAMA : the journal of the American Medical Association, 2001-06, Vol.285 (21), p.2743

2001

Volltextzugriff (PDF)

High-risk features of lupus nephritis : importance of race and clinical and histological factors in 166 patients

Nephrology, dialysis, transplantation, 1995-01, Vol.10 (9), p.1620-1628

1995

Volltextzugriff (PDF)

Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor

The Journal of immunology (1950), 1993-10, Vol.151 (8), p.4081-4089

1993

Volltextzugriff (PDF)

Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy

Annals of internal medicine, 1993-09, Vol.119 (5), p.366

1993

Volltextzugriff (PDF)

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

The New England journal of medicine, 1986-03, Vol.314 (10), p.614

1986

Volltextzugriff (PDF)

Outcome criteria for lupus nephritis trials: A critical overview

Lupus, 1998-01, Vol.7 (9), p.622-629

1998

Volltextzugriff (PDF)

Renal biopsy in lupus nephritis

Lupus, 1998-01, Vol.7 (9), p.611-617

1998

Volltextzugriff (PDF)

Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 2: Inflammatory bowel disease, systemic vasculitis, and therapeutic toxicity

Annals of internal medicine, 1998-07, Vol.129 (1), p.49

1998

Volltextzugriff (PDF)

Effect of transforming growth factor-beta on early and late activation events in human T cells

The Journal of immunology (1950), 1993-04, Vol.150 (8 Pt 1), p.3109-3118

1993

Volltextzugriff (PDF)

Pulse cyclophosphamide for severe neuropsychiatric lupus

QJM : An International Journal of Medicine, 1991-12, Vol.81 (296), p.975-984

1991

Volltextzugriff (PDF)

A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy

Clinical nephrology, 1999-08, Vol.52 (2), p.67

1999

Volltextzugriff (PDF)

Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever

Cell, 1997-08, Vol.90 (4), p.797-807

1997

Volltextzugriff (PDF)

A High-Resolution Genetic Map of the Familial Mediterranean Fever Candidate Region Allows Identification of Haplotype-Sharing among Ethnic Groups

Genomics (San Diego, Calif.), 1997-09, Vol.44 (3), p.280-291

1997

Volltextzugriff (PDF)

Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 1: rheumatologic and renal diseases

Annals of internal medicine, 1998-06, Vol.128 (12 Pt 1), p.1021

1998

Volltextzugriff (PDF)

Linkage disequilibrium mapping places the gene causing familial Mediterranean fever close to D16S246

American journal of human genetics, 1996-03, Vol.58 (3), p.523-534

1996

Volltextzugriff (PDF)

Renal histopathologic alterations in patients treated with cyclosporine for uveitis

The New England journal of medicine, 1986-05, Vol.314 (20), p.1293-1298

1986

Volltextzugriff (PDF)

1 – 25 von 222

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(188)
Mit Volltextzugriff
(126)

Publikationsform

Artikel
(220)
Buchkapitel
(2)

Sprache

Englisch
(221)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(180)
Science & Technology
(169)
Life Sciences & Biomedicine
(167)
Biological And Medical Sciences
(88)
Adult
(78)
Medical Sciences
(77)
Female
(75)
Male
(66)
Middle Aged
(47)
General & Internal Medicine
(39)
Medicine, General & Internal
(39)
Immunology
(33)
Lupus Erythematosus, Systemic - Immunology
(33)
Rheumatology
(32)
Adolescent
(30)
Immunosuppressive Agents - Therapeutic Use
(28)
Lupus Erythematosus, Systemic - Complications
(27)
Cyclophosphamide - Therapeutic Use
(24)
Lupus Nephritis - Drug Therapy
(23)
Urology & Nephrology
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis

Clinical presentation and monitoring of lupus nephritis

Nephrotic syndrome: an under‐recognised immune‐mediated complication of non‐myeloablative allogeneic haematopoietic cell transplantation

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial

Mapping of a Gene Causing Familial Mediterranean Fever to the Short Arm of Chromosome 16

Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates

Treatment of Type B Insulin Resistance: A Novel Approach to Reduce Insulin Receptor Autoantibodies

Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis

Enzyme replacement therapy in Fabry disease: a randomized controlled trial

High-risk features of lupus nephritis : importance of race and clinical and histological factors in 166 patients

Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor

Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

Outcome criteria for lupus nephritis trials: A critical overview

Renal biopsy in lupus nephritis

Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 2: Inflammatory bowel disease, systemic vasculitis, and therapeutic toxicity

Effect of transforming growth factor-beta on early and late activation events in human T cells

Pulse cyclophosphamide for severe neuropsychiatric lupus

A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy

Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever

A High-Resolution Genetic Map of the Familial Mediterranean Fever Candidate Region Allows Identification of Haplotype-Sharing among Ethnic Groups

Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 1: rheumatologic and renal diseases

Linkage disequilibrium mapping places the gene causing familial Mediterranean fever close to D16S246

Renal histopathologic alterations in patients treated with cyclosporine for uveitis

Suchergebnisse filtern